532039-BOM

Zenotech Laboratories Ltd.

44.00-1.1 (-2.44%)
28 Jul, 3:30 PM

Annual Reports and Financial Documents

Zenotech Laboratories Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Zenotech Laboratories Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201814 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Submission of Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026.
  • Board Meeting13 Jul 2026
    Board Meeting Intimation for Considering And Approving Unaudited Standalone Financial Results Of The Company For The Quarter Ended June 30, 2026.
    Zenotech Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2026 ,inter alia, to consider and approve Unaudited Standalone ....
  • Closure of Trading Window30 Jun 2026
    Closure of Trading Window
    Closure of Trading Window
  • Reg.24(A)-Annual Secretarial Compliance27 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Submission of Annual Secretarial Compliance Report for the financial year 2025-26
  • Newspaper Publication30 Apr 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Copies of extract of Audited Standalone Financial Results of the Company for the quarter and financial year ended March 31, 2026 as published in today''s newspaper, i.e., April 30, 2026.
  • Outcome of Board Meeting29 Apr 2026
    Board Meeting Outcome for Outcome Of The Board Meeting Held On April 29, 2026
    Submission of Audited Standalone Financial Results for the quarter and financial year ended March 31, 2026
  • Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A28 Apr 2026
    Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
    <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
  • Board Meeting23 Apr 2026
    Board Meeting Intimation for Considering And Approving Audited Standalone Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2026.
    Zenotech Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2026 ,inter alia, to consider and approve Audited Standalone Financial ....
  • General10 Apr 2026
    Clarification On Price Movement
    Clarification on Price Movement is enclosed herewith
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20187 Apr 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Submission of Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026.
  • Closure of Trading Window26 Mar 2026
    Closure of Trading Window
    Intimation for Trading Window Closure
  • Postal Ballot12 Mar 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
    Submission of Scrutinizer''s Report dated March 12, 2026 for Postal Ballot event.
  • Postal Ballot12 Mar 2026
    Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
    Result of the Postal Ballot by Remote e-Voting process and submission of Scrutinizer''s Report dated March 12, 2026.
  • Newspaper Publication10 Feb 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Copies of Newspaper Advertisement published today i.e., February 10, 2026 regarding Notice of Postal Ballot & e-voting with Digital Signature affixed.
  • Newspaper Publication10 Feb 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Copies of Newspaper Advertisement published today i.e., February 10, 2026, regarding Notice of Postal Ballot & e-voting.
  • Postal Ballot9 Feb 2026
    Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
    Notice of Postal Ballot dated January 23, 2026 is attached.
  • Newspaper Publication24 Jan 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Copies of extracts of Standalone Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2025, published in newspapers today, i.e., January 24, 2026.
  • Outcome of Board Meeting23 Jan 2026
    Board Meeting Outcome for Outcome Of The Board Meeting Held On January 23, 2026
    Outcome of the Board Meeting held today, i.e., January 23, 2026
  • Board Meeting16 Jan 2026
    Board Meeting Intimation for Approval Of Unaudited Standalone Financial Results For The Quarter And Nine Months Ended December 31, 2025.
    Zenotech Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2026 ,inter alia, to consider and approve Unaudited Standalone ....
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20189 Jan 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 is attached.

Frequently Asked Questions

Where can I download the annual report of Zenotech Laboratories Ltd.?
Annual reports of Zenotech Laboratories Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Zenotech Laboratories Ltd.?
Quarterly earnings results and presentations of Zenotech Laboratories Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Zenotech Laboratories Ltd. publish earnings call transcripts?
Earnings call transcripts of Zenotech Laboratories Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Zenotech Laboratories Ltd.?
Investor presentations and annual day presentations of Zenotech Laboratories Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Zenotech Laboratories Ltd.?
Corporate announcements and regulatory filings of Zenotech Laboratories Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Zenotech Laboratories Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Zenotech Laboratories Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Zenotech Laboratories Ltd.?
The ISIN (International Securities Identification Number) of Zenotech Laboratories Ltd. is INE486F01012. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Zenotech Laboratories Ltd. listed?
Zenotech Laboratories Ltd. is listed on NSE and BSE. The NSE symbol is 532039-BOM and the BSE code is -.
Where can I find the shareholding pattern of Zenotech Laboratories Ltd.?
The quarterly shareholding pattern of Zenotech Laboratories Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Zenotech Laboratories Ltd. on Sharpely?
Share price data for Zenotech Laboratories Ltd. is updated as of 28 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.